Skip to main content
862 TRAVEL TIME TO TREATING CENTER, BUT NOT RACE OR ETHNICITY IS ASSOCIATED WITH DIAGNOSTIC DELAY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE.
Sa1635: IMPACT OF NUTRITION AND GROWTH MEASURES ON POUCHITIS FOLLOWING PROCTOCOLECTOMY FOR PEDIATRIC ULCERATIVE COLITIS.
577 INTER-RATER AGREEMENT ON IMAGING FINDINGS OF CHRONIC PANCREATITIS IN A PEDIATRIC COHORT.
Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice.
Sa1851 LOW PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE IN ADOLESCENTS WITH INFLAMMATORY BOWEL DISEASE.
Mo1901 CHILDREN WITH INFLAMMATORY BOWEL DISEASE EXPERIENCE HIGH RATES OF TRAUMA SECONDARY TO MEDICAL TREATMENT.
Mo1894 APPROACH TO TRANSGENDER AND GENDER NON-CONFORMING (TGNC) YOUTH IN A PEDIATRIC INFLAMMATORY BOWEL DISEASE CENTER.
Tu1710 – Ustekinumab to Treat Pediatric Patients with Crohn's Disease: A Single Center Experience.
Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation.
P019 DEPRESSION PREDICTS LENGTH OF HOSPITAL STAY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE.